20-104
Showing 1 - 25 of >10,000
Covid19 Trial in Taipei, Taoyuan (AD17002, Placebo (Formulation buffer))
Recruiting
- Covid19
- AD17002
- Placebo (Formulation buffer)
-
Taipei, Taiwan
- +1 more
Sep 15, 2022
Pneumococcal Disease Trial in Japan, Korea, Republic of, Taiwan (20vPnC, Saline, 13vPnC)
Completed
- Pneumococcal Disease
- 20vPnC
- +3 more
-
Itoshima, Fukuoka, Japan
- +27 more
Dec 5, 2022
Respiratory Syncytial Virus Prevention Trial in Japan (Ad26/protein preF RSV Vaccine, Placebo)
Recruiting
- Respiratory Syncytial Virus Prevention
- Ad26/protein preF RSV Vaccine
- Placebo
-
Akashi-shi, Japan
- +29 more
Aug 2, 2022
Resistant Hypertension Trial in Worldwide (Experimental drug, Placebo)
Recruiting
- Resistant Hypertension
- Experimental drug
- Placebo
-
Guntersville, Alabama
- +28 more
Jan 13, 2023
HER2 Low and Describe SoC, Treatment Patterns, and Outcome in
Completed
- Breast Cancer
- None (Observational study)
-
Pittsburgh, Pennsylvania
- +12 more
May 25, 2022
Harassment, Non-Sexual, Harassment, Sexual, Bullying, Workplace Trial in United States (Mentoring program)
Enrolling by invitation
- Harassment, Non-Sexual
- +6 more
- Mentoring program
-
Phoenix, Arizona
- +18 more
May 16, 2022
Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)
Active, not recruiting
- Advanced Solid Malignancy
- +13 more
-
Los Angeles, California
- +33 more
Dec 22, 2022
Advanced or Metastatic Breast Cancer, ER+ve Advanced or Metastatic Breast Cancer Trial in Worldwide (AZD5363 when combined with
Completed
- Advanced or Metastatic Breast Cancer
- ER+ve Advanced or Metastatic Breast Cancer
- AZD5363 when combined with weekly paclitaxel.
- +2 more
-
Plovdiv, Bulgaria
- +40 more
Dec 23, 2022
Small Cell Lung Carcinoma Trial in Worldwide (AMG 757, Pembrolizumab, CRS Mitigation Strategies)
Recruiting
- Small Cell Lung Carcinoma
- AMG 757
- +2 more
-
Duarte, California
- +34 more
Dec 6, 2022
Biliary Tract Cancer Trial in Worldwide (Rilvegostomig, Placebo, Capecitabine)
Not yet recruiting
- Biliary Tract Cancer
- Rilvegostomig
- +4 more
-
Clayton, Australia
- +65 more
Oct 26, 2023
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-75348780)
Recruiting
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
-
Birmingham, Alabama
- +43 more
Jan 27, 2023
Fibrolamellar Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, DRP-104)
Not yet recruiting
- Fibrolamellar Hepatocellular Carcinoma
-
Baltimore, MarylandJohns Hopkins SKCCC
Aug 30, 2023
Pulmonary Ventilation Trial in Taipei (Ventilator breathing tube F2220, Ventilator breathing tube F2216, Ventilator breathing
Withdrawn
- Pulmonary Ventilation
- Ventilator breathing tube F2220
- +7 more
-
Taipei, TaiwanMacKay Memorial Hospital
Jun 3, 2020
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- prednisone
-
Birmingham, Alabama
- +120 more
Dec 22, 2022
Skin Diseases Trial in Chicago (Dupilumab)
Not yet recruiting
- Skin Diseases
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago
Jan 9, 2023
Recurrent Pericarditis Trial in Richmond (RPH-104, Placebo)
Not yet recruiting
- Recurrent Pericarditis
- RPH-104
- Placebo
-
Richmond, VirginiaVirginia Commonwealth University
Jun 2, 2022
Desmoplastic Small Round Cell Tumor Trial in Worldwide (Ramucirumab, Cyclophosphamide, Vinorelbine)
Active, not recruiting
- Desmoplastic Small Round Cell Tumor
- Ramucirumab
- +2 more
-
Phoenix, Arizona
- +50 more
Jan 18, 2023